CPhI Annual Report 2020 highlights cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China. Continuous Bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at least some single use technologies. CPhI Annual Report – launched ahead of the first CPhI Festival of Pharma (5-16 […]
